2008
DOI: 10.1007/s10198-008-0101-x
|View full text |Cite
|
Sign up to set email alerts
|

Comparing methodologies for the cost estimation of hospital services

Abstract: The aim of the study was to determine whether the total cost estimate of a hospital service remains reliable when the cost components of bottom-up microcosting were replaced by the cost components of top-down microcosting or gross costing. Total cost estimates were determined in representative general hospitals in the Netherlands for appendectomy, normal delivery, stroke and acute myocardial infarction for 2005. It was concluded that restricting the use of bottom-up microcosting to those cost components that h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
234
0
7

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 201 publications
(245 citation statements)
references
References 11 publications
4
234
0
7
Order By: Relevance
“…Costs remain understudied relative to effectiveness [3] and the lack of transparent, accurate cost data impacts the validity of CEAs and may lead to inappropriate reimbursement decisions, as well as preventing their use at a level commensurate with their promise. [4,5] The cost and effectiveness data for CEAs may be obtained in two ways: [6] Dollar by dollar alongside a clinical trial (or population-based study)-often called microcosting. Alternatively, a synthesis of literature-based sources (and institutional experience, expert opinion and assumptions where these are unavailable) may provide relevant figures to populate a decision-analytic model such as a decision tree or Markov model-often called gross or macrocosting.…”
Section: A Brief Overview Of Costing In Economic Evaluationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Costs remain understudied relative to effectiveness [3] and the lack of transparent, accurate cost data impacts the validity of CEAs and may lead to inappropriate reimbursement decisions, as well as preventing their use at a level commensurate with their promise. [4,5] The cost and effectiveness data for CEAs may be obtained in two ways: [6] Dollar by dollar alongside a clinical trial (or population-based study)-often called microcosting. Alternatively, a synthesis of literature-based sources (and institutional experience, expert opinion and assumptions where these are unavailable) may provide relevant figures to populate a decision-analytic model such as a decision tree or Markov model-often called gross or macrocosting.…”
Section: A Brief Overview Of Costing In Economic Evaluationsmentioning
confidence: 99%
“…These costs are difficult to ascertain and assigning them to specific procedures suffers from an irreducible arbitrariness and sensitivity to methods. [4,18,19] …”
Section: Costs Not Consideredmentioning
confidence: 99%
“…The concept of delivering a service has been researched since the twentieth century and widely applied in numerous sectors such as aerospace, information technology (IT), health care, finance, civil construction, and defence areas (Jian and Hong-fu 2004, Ward and Graves 2007, Tan et al 2009). The delivery of a service can, for example, include training, logistics, maintenance, consulting, auditing, human resources, financial management, health care and IT services (CMMI 2009).…”
Section: Service Costingmentioning
confidence: 99%
“…They provide insight into the effects and associated costs of the treatment, and supply policy and decision makers in health care with useful information to support their decisions (11,12). Until this point, 2 economic evaluations have investigated the value of HMW-HA for knee OA in a realworld clinical setting (13,14).…”
Section: Introductionmentioning
confidence: 99%